Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2014 - 2016)

Viridian Therapeutics, Inc.\DE's Current Leases history runs 3 years deep, the most recent figure standing at $4000.0 for Q4 2016.

• In Q4 2016, Current Leases fell 95.45% year-over-year to $4000.0; the TTM figure through Dec 2016 stood at $4000.0 (down 95.45% YoY), while the FY2016 annual figure was $4000.0, down 95.45% from the prior year.
• Current Leases for Q4 2016 stood at $4000.0, down from $88000.0 in the prior quarter.
• The five-year high for Current Leases was $88000.0 in Q4 2015, with the low at $4000.0 in Q4 2016.
• The 3-year median for Current Leases is $80000.0 (2014), against an average of $57333.3.
• The sharpest annual moves came in 2015 and 2016: Current Leases increased 10.0% in 2015, then slumped 95.45% in 2016.
• Viridian Therapeutics, Inc.\DE's Current Leases stood at $80000.0 in 2014, then climbed by 10.0% to $88000.0 in 2015, then plunged by 95.45% to $4000.0 in 2016.
• Business Quant data shows VRDN's Current Leases at $4000.0 in Q4 2016, $88000.0 in Q4 2015, and $80000.0 in Q4 2014.